Lo, how the mighty have fallen.
Amyris, the company founded by UC Berkeley’s Jay Keasling and his students with the promise to bring competitive clean-burning cellulose-based fuels to a gas pump near you, is heading the Home Shopping Network.
As we’ve noted endless time before, Amyris failed in in basic promise, despite many millions from Bill Gates, Arab oil royalty, and an Asian government, and has abandoned all plans to make fuel from bacterial excrement.
Instead, the microbes are secreting chemicals to smear on your skin.
From a company press release:
Biossance™, the consumer beauty brand from Amyris, Inc. (AMRS), today announced its anticipated launch on leading live content retailer HSN on February 18th, 2016 during the Beauty Report with Amy Morrison. The first product to be featured from the exciting new skincare collection will be Biossance™ The Revitalizer, a breakthrough moisturizer that helps skin by using one of the emollients already found naturally within the body. Amyris plans to feature an expanded line of several other Biossance products during 2016, which will also be available for sale across HSN’s platforms, including TV, mobile and online via HSN’s website (www.HSN.com).“We are delighted to welcome the Biossance brand to HSN,” said Alicia Valencia, Senior Vice President of Beauty at HSN. “Our customers are always searching for innovative new products that are environmentally friendly and will enhance their current beauty regime. Biossance is a perfect addition to our growing portfolio of top beauty brands and I look forward to debuting it for our customers this month.”
“As a leading industrial bioscience company, we are pleased to join with HSN, a leader in showcasing innovative new products, to celebrate the on-air launch of Biossance The Revitalizer,” said Caroline Hadfield, Senior Vice President, Personal Care, at Amyris. “This marks the next step in our plans to bring the Biossance brand to cosmetics consumers both on- and offline.”
And, yes, the Amyris founders, aided by Gates, originally promised to bring the world a bacteria-created version of the world’s leading anti-malarial drug at a price much cheaper than the natural version.
They failed at that, too.